why choose us

First received: December 05, 2023

Clinical Trial: Middle Meningeal Artery Embolization (MMAE) Outcomes for Chronic Subdural Hematoma (cSDH)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Chronic Subdural Hematoma

Study Type: OBSERVATIONAL


Official Title: Outcomes of Middle Meningeal Artery for Treatment of Chronic Subdural Hematoma; Middle Meningeal Artery Embolization for Chronic Subdural Hematoma (MESH)

Brief Summary: This multi-center retrospective cohort study aims to investigate the real-world outcomes of chronic subdural hematoma treated with MMAE, including clinical effectiveness, recurrence rates, and safety profile.

Read more